The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Postpartum Hemorrhage Treatment Device Market Research Report 2025
Synopsis
Postpartum hemorrhage is the most common form of obstetric hemorrhage and is one of the leading cause of maternal mortality. According to the data revealed by WHO, about one quarter of the maternal deaths occur due to postpartum hemorrhage. Postpartum hemorrhage is classified as primary PPH where blood loss is less than 500 ml and secondary PPH having blood loss more than 500ml. Currently, active management of third labor is practiced for preventing PPH which is administered directly after the child birth.
The global Postpartum Hemorrhage Treatment Device market was valued at US$ 726.2 million in 2023 and is anticipated to reach US$ 895.2 million by 2030, witnessing a CAGR of 3.0% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Postpartum Hemorrhage Treatment Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Postpartum Hemorrhage Treatment Device.
Report Scope
The Postpartum Hemorrhage Treatment Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Postpartum Hemorrhage Treatment Device market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Postpartum Hemorrhage Treatment Device manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bactiguard
R. Bard
Cook Medical
Davol
3rd Stone Design
Teleflexorporated
Utah Medical Products
Becton Dickinson
Ge Healthcare
Inpress Technologies
Zoex Niasg
Segment by Type
Uterine Balloon Tamponade
Uniject Prefilled Injection System
Other
Segment by Application
Hospitals
Clinics
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Postpartum Hemorrhage Treatment Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Postpartum Hemorrhage Treatment Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Postpartum hemorrhage is the most common form of obstetric hemorrhage and is one of the leading cause of maternal mortality. According to the data revealed by WHO, about one quarter of the maternal deaths occur due to postpartum hemorrhage. Postpartum hemorrhage is classified as primary PPH where blood loss is less than 500 ml and secondary PPH having blood loss more than 500ml. Currently, active management of third labor is practiced for preventing PPH which is administered directly after the child birth.
The global Postpartum Hemorrhage Treatment Device market was valued at US$ 726.2 million in 2023 and is anticipated to reach US$ 895.2 million by 2030, witnessing a CAGR of 3.0% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Postpartum Hemorrhage Treatment Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Postpartum Hemorrhage Treatment Device.
Report Scope
The Postpartum Hemorrhage Treatment Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Postpartum Hemorrhage Treatment Device market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Postpartum Hemorrhage Treatment Device manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bactiguard
R. Bard
Cook Medical
Davol
3rd Stone Design
Teleflexorporated
Utah Medical Products
Becton Dickinson
Ge Healthcare
Inpress Technologies
Zoex Niasg
Segment by Type
Uterine Balloon Tamponade
Uniject Prefilled Injection System
Other
Segment by Application
Hospitals
Clinics
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Postpartum Hemorrhage Treatment Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Postpartum Hemorrhage Treatment Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Postpartum Hemorrhage Treatment Device Market Overview
1.1 Product Overview and Scope of Postpartum Hemorrhage Treatment Device
1.2 Postpartum Hemorrhage Treatment Device Segment by Type
1.2.1 Global Postpartum Hemorrhage Treatment Device Market Value Comparison by Type (2024-2030)
1.2.2 Uterine Balloon Tamponade
1.2.3 Uniject Prefilled Injection System
1.2.4 Other
1.3 Postpartum Hemorrhage Treatment Device Segment by Application
1.3.1 Global Postpartum Hemorrhage Treatment Device Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Global Postpartum Hemorrhage Treatment Device Market Size Estimates and Forecasts
1.4.1 Global Postpartum Hemorrhage Treatment Device Revenue 2019-2030
1.4.2 Global Postpartum Hemorrhage Treatment Device Sales 2019-2030
1.4.3 Global Postpartum Hemorrhage Treatment Device Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Postpartum Hemorrhage Treatment Device Market Competition by Manufacturers
2.1 Global Postpartum Hemorrhage Treatment Device Sales Market Share by Manufacturers (2019-2024)
2.2 Global Postpartum Hemorrhage Treatment Device Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Postpartum Hemorrhage Treatment Device Average Price by Manufacturers (2019-2024)
2.4 Global Postpartum Hemorrhage Treatment Device Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Postpartum Hemorrhage Treatment Device, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Postpartum Hemorrhage Treatment Device, Product Type & Application
2.7 Postpartum Hemorrhage Treatment Device Market Competitive Situation and Trends
2.7.1 Postpartum Hemorrhage Treatment Device Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Postpartum Hemorrhage Treatment Device Players Market Share by Revenue
2.7.3 Global Postpartum Hemorrhage Treatment Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Postpartum Hemorrhage Treatment Device Retrospective Market Scenario by Region
3.1 Global Postpartum Hemorrhage Treatment Device Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Postpartum Hemorrhage Treatment Device Global Postpartum Hemorrhage Treatment Device Sales by Region: 2019-2030
3.2.1 Global Postpartum Hemorrhage Treatment Device Sales by Region: 2019-2024
3.2.2 Global Postpartum Hemorrhage Treatment Device Sales by Region: 2025-2030
3.3 Global Postpartum Hemorrhage Treatment Device Global Postpartum Hemorrhage Treatment Device Revenue by Region: 2019-2030
3.3.1 Global Postpartum Hemorrhage Treatment Device Revenue by Region: 2019-2024
3.3.2 Global Postpartum Hemorrhage Treatment Device Revenue by Region: 2025-2030
3.4 North America Postpartum Hemorrhage Treatment Device Market Facts & Figures by Country
3.4.1 North America Postpartum Hemorrhage Treatment Device Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Postpartum Hemorrhage Treatment Device Sales by Country (2019-2030)
3.4.3 North America Postpartum Hemorrhage Treatment Device Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Postpartum Hemorrhage Treatment Device Market Facts & Figures by Country
3.5.1 Europe Postpartum Hemorrhage Treatment Device Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Postpartum Hemorrhage Treatment Device Sales by Country (2019-2030)
3.5.3 Europe Postpartum Hemorrhage Treatment Device Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Postpartum Hemorrhage Treatment Device Market Facts & Figures by Country
3.6.1 Asia Pacific Postpartum Hemorrhage Treatment Device Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Postpartum Hemorrhage Treatment Device Sales by Country (2019-2030)
3.6.3 Asia Pacific Postpartum Hemorrhage Treatment Device Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Postpartum Hemorrhage Treatment Device Market Facts & Figures by Country
3.7.1 Latin America Postpartum Hemorrhage Treatment Device Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Postpartum Hemorrhage Treatment Device Sales by Country (2019-2030)
3.7.3 Latin America Postpartum Hemorrhage Treatment Device Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Postpartum Hemorrhage Treatment Device Market Facts & Figures by Country
3.8.1 Middle East and Africa Postpartum Hemorrhage Treatment Device Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Postpartum Hemorrhage Treatment Device Sales by Country (2019-2030)
3.8.3 Middle East and Africa Postpartum Hemorrhage Treatment Device Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Postpartum Hemorrhage Treatment Device Sales by Type (2019-2030)
4.1.1 Global Postpartum Hemorrhage Treatment Device Sales by Type (2019-2024)
4.1.2 Global Postpartum Hemorrhage Treatment Device Sales by Type (2025-2030)
4.1.3 Global Postpartum Hemorrhage Treatment Device Sales Market Share by Type (2019-2030)
4.2 Global Postpartum Hemorrhage Treatment Device Revenue by Type (2019-2030)
4.2.1 Global Postpartum Hemorrhage Treatment Device Revenue by Type (2019-2024)
4.2.2 Global Postpartum Hemorrhage Treatment Device Revenue by Type (2025-2030)
4.2.3 Global Postpartum Hemorrhage Treatment Device Revenue Market Share by Type (2019-2030)
4.3 Global Postpartum Hemorrhage Treatment Device Price by Type (2019-2030)
5 Segment by Application
5.1 Global Postpartum Hemorrhage Treatment Device Sales by Application (2019-2030)
5.1.1 Global Postpartum Hemorrhage Treatment Device Sales by Application (2019-2024)
5.1.2 Global Postpartum Hemorrhage Treatment Device Sales by Application (2025-2030)
5.1.3 Global Postpartum Hemorrhage Treatment Device Sales Market Share by Application (2019-2030)
5.2 Global Postpartum Hemorrhage Treatment Device Revenue by Application (2019-2030)
5.2.1 Global Postpartum Hemorrhage Treatment Device Revenue by Application (2019-2024)
5.2.2 Global Postpartum Hemorrhage Treatment Device Revenue by Application (2025-2030)
5.2.3 Global Postpartum Hemorrhage Treatment Device Revenue Market Share by Application (2019-2030)
5.3 Global Postpartum Hemorrhage Treatment Device Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Bactiguard
6.1.1 Bactiguard Corporation Information
6.1.2 Bactiguard Description and Business Overview
6.1.3 Bactiguard Postpartum Hemorrhage Treatment Device Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Bactiguard Postpartum Hemorrhage Treatment Device Product Portfolio
6.1.5 Bactiguard Recent Developments/Updates
6.2 R. Bard
6.2.1 R. Bard Corporation Information
6.2.2 R. Bard Description and Business Overview
6.2.3 R. Bard Postpartum Hemorrhage Treatment Device Sales, Revenue and Gross Margin (2019-2024)
6.2.4 R. Bard Postpartum Hemorrhage Treatment Device Product Portfolio
6.2.5 R. Bard Recent Developments/Updates
6.3 Cook Medical
6.3.1 Cook Medical Corporation Information
6.3.2 Cook Medical Description and Business Overview
6.3.3 Cook Medical Postpartum Hemorrhage Treatment Device Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Cook Medical Postpartum Hemorrhage Treatment Device Product Portfolio
6.3.5 Cook Medical Recent Developments/Updates
6.4 Davol
6.4.1 Davol Corporation Information
6.4.2 Davol Description and Business Overview
6.4.3 Davol Postpartum Hemorrhage Treatment Device Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Davol Postpartum Hemorrhage Treatment Device Product Portfolio
6.4.5 Davol Recent Developments/Updates
6.5 3rd Stone Design
6.5.1 3rd Stone Design Corporation Information
6.5.2 3rd Stone Design Description and Business Overview
6.5.3 3rd Stone Design Postpartum Hemorrhage Treatment Device Sales, Revenue and Gross Margin (2019-2024)
6.5.4 3rd Stone Design Postpartum Hemorrhage Treatment Device Product Portfolio
6.5.5 3rd Stone Design Recent Developments/Updates
6.6 Teleflexorporated
6.6.1 Teleflexorporated Corporation Information
6.6.2 Teleflexorporated Description and Business Overview
6.6.3 Teleflexorporated Postpartum Hemorrhage Treatment Device Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Teleflexorporated Postpartum Hemorrhage Treatment Device Product Portfolio
6.6.5 Teleflexorporated Recent Developments/Updates
6.7 Utah Medical Products
6.6.1 Utah Medical Products Corporation Information
6.6.2 Utah Medical Products Description and Business Overview
6.6.3 Utah Medical Products Postpartum Hemorrhage Treatment Device Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Utah Medical Products Postpartum Hemorrhage Treatment Device Product Portfolio
6.7.5 Utah Medical Products Recent Developments/Updates
6.8 Becton Dickinson
6.8.1 Becton Dickinson Corporation Information
6.8.2 Becton Dickinson Description and Business Overview
6.8.3 Becton Dickinson Postpartum Hemorrhage Treatment Device Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Becton Dickinson Postpartum Hemorrhage Treatment Device Product Portfolio
6.8.5 Becton Dickinson Recent Developments/Updates
6.9 Ge Healthcare
6.9.1 Ge Healthcare Corporation Information
6.9.2 Ge Healthcare Description and Business Overview
6.9.3 Ge Healthcare Postpartum Hemorrhage Treatment Device Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Ge Healthcare Postpartum Hemorrhage Treatment Device Product Portfolio
6.9.5 Ge Healthcare Recent Developments/Updates
6.10 Inpress Technologies
6.10.1 Inpress Technologies Corporation Information
6.10.2 Inpress Technologies Description and Business Overview
6.10.3 Inpress Technologies Postpartum Hemorrhage Treatment Device Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Inpress Technologies Postpartum Hemorrhage Treatment Device Product Portfolio
6.10.5 Inpress Technologies Recent Developments/Updates
6.11 Zoex Niasg
6.11.1 Zoex Niasg Corporation Information
6.11.2 Zoex Niasg Postpartum Hemorrhage Treatment Device Description and Business Overview
6.11.3 Zoex Niasg Postpartum Hemorrhage Treatment Device Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Zoex Niasg Postpartum Hemorrhage Treatment Device Product Portfolio
6.11.5 Zoex Niasg Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Postpartum Hemorrhage Treatment Device Industry Chain Analysis
7.2 Postpartum Hemorrhage Treatment Device Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Postpartum Hemorrhage Treatment Device Production Mode & Process
7.4 Postpartum Hemorrhage Treatment Device Sales and Marketing
7.4.1 Postpartum Hemorrhage Treatment Device Sales Channels
7.4.2 Postpartum Hemorrhage Treatment Device Distributors
7.5 Postpartum Hemorrhage Treatment Device Customers
8 Postpartum Hemorrhage Treatment Device Market Dynamics
8.1 Postpartum Hemorrhage Treatment Device Industry Trends
8.2 Postpartum Hemorrhage Treatment Device Market Drivers
8.3 Postpartum Hemorrhage Treatment Device Market Challenges
8.4 Postpartum Hemorrhage Treatment Device Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
